Literature DB >> 33010889

Crystal structure of the HMG domain of human BAF57 and its interaction with four-way junction DNA.

Yunseok Heo1, Jae-Hyun Park1, Jongmin Kim1, Jeongmin Han1, Ji-Hye Yun2, Weontae Lee3.   

Abstract

The SWI/SNF chromatin remodeling complex plays important roles in gene regulation and it is classified as the SWI/SNF complex in yeast and BAF complex in vertebrates. BAF57, one of the subunits that forms the chromatin remodeling complex core, is well conserved in the BAF complex of vertebrates, which is replaced by bap111 in the Drosophila BAP complex and does not have a counterpart in the yeast SWI/SNF complex. This suggests that BAF57 is a key component of the chromatin remodeling complex in higher eukaryotes. BAF57 contains a HMG domain, which is widely distributed among various proteins and functions as a DNA binding motif. Most proteins with HMG domain bind to four-way junction (4WJ) DNA. Here, we report the crystal structure of the HMG domain of BAF57 (BAF57HMG) at a resolution of 2.55 Å. The structure consists of three α-helices and adopts an L-shaped form. The overall structure is stabilized by a hydrophobic core, which is formed by hydrophobic residues. The binding affinity between BAF57HMG and 4WJ DNA is determined as a 295.83 ± 1.05 nM using a fluorescence quenching assay, and the structure revealed 4WJ DNA binding site of BAF57HMG. Our data will serve structural basis in understanding the roles of BAF57 during chromatin remodeling process.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  4WJ DNA; BAF57; DNA binding; HMG domain; Hydrophobic core

Year:  2020        PMID: 33010889     DOI: 10.1016/j.bbrc.2020.09.094

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  1 in total

1.  SMARCE1 promotes neuroblastoma tumorigenesis through assisting MYCN-mediated transcriptional activation.

Authors:  Xiaosong Hu; Ruochen Liu; Jianbing Hou; Wen Peng; Sicheng Wan; Minghao Xu; Yongsen Li; Guanghui Zhang; Xuan Zhai; Ping Liang; Hongjuan Cui
Journal:  Oncogene       Date:  2022-08-17       Impact factor: 8.756

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.